Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose Albaconazole vs Fluconazole vs Placebo in Acute Candida Vulvovaginitis
2023-504727-32-00Phase 2Completed
- Sponsor
- Palau Pharma
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial of albaconazole in vulvovaginal candidiasis (VVC) (3 arms), sponsored by Palau Pharma. Primary endpoint: Clinical cure at Final Visit (albaconazole vs placebo). Started Sep 2023; status: completed.
02
Drugs
albaconazole
03
Conditions
vulvovaginal candidiasis (VVC)
Beyond the preview
Go deeper on 2023-504727-32-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-504727-32-00.